We are live on ! Find out more
CELGZ

Celgene Corporation Contingent Value Rights
CELGZ

Delisted

CELGZ was delisted on the 29th of November, 2019.

Back to rankings

24 hedge funds and large institutions have $4.11M invested in Celgene Corporation Contingent Value Rights in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

4% more funds holding

Funds holding: 23 → 24 (+1)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

18% less capital invested

Capital invested by funds: $5.03M → $4.11M (-$922K)

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DC
Davenport & Co
Virginia
+$16.6K
2
Wells Fargo
Wells Fargo
California
+$517
3
Citigroup
Citigroup
New York
+$277
4
TRCT
Tower Research Capital (TRC)
New York
+$55

Top Sellers

Rank Fund Capital Flow
1
FA
FCG Advisors
New Jersey
-$453K
2
Millennium Management
Millennium Management
New York
-$89.4K
3
WJA
Williams Jones & Associates
New York
-$31.8K
4
U
UBS
Switzerland
-$4K
5
State Street
State Street
Massachusetts
-$55
Name Holding Trade Value Shares
Change 		Change in
Stake
OM
1
Opaleye Management
Massachusetts
$1.72M – – –
Millennium Management
2
Millennium Management
New York
$887K -$89.4K -32,300 -9%
FA
3
FCG Advisors
New Jersey
$841K -$453K -163,869 -34%
DC
4
Davenport & Co
Virginia
$185K +$16.6K +6,000 +9%
First Manhattan
5
First Manhattan
New York
$135K – – –
California Public Employees Retirement System
6
California Public Employees Retirement System
California
$69K – – –
Citigroup
7
Citigroup
New York
$63K +$277 +100 +0.4%
State Street
8
State Street
Massachusetts
$50K -$55 -20 -0.1%
CL
9
CSS LLC
Illinois
$45K – – –
PC
10
Pomelo Capital
New York
$39K – – –
WJA
11
Williams Jones & Associates
New York
$30K -$31.8K -11,500 -50%
BPBT
12
Boston Private Bank & Trust
Massachusetts
$11K – – –
Bank of America
13
Bank of America
North Carolina
$10K – – –
Morgan Stanley
14
Morgan Stanley
New York
$9K – – –
TRCT
15
Tower Research Capital (TRC)
New York
$6K +$55 +20 +0.9%
Ameriprise
16
Ameriprise
Minnesota
$5K – – –
Manulife (Manufacturers Life Insurance)
17
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K – – –
Deutsche Bank
18
Deutsche Bank
Germany
$3K – – –
MSTVIM
19
Messner & Smith Theme Value Investment Management
California
$2K – – –
GSC
20
Ground Swell Capital
South Carolina
$1K +$1.11K +400 New
U
21
UBS
Switzerland
– -$4K -1,517 Closed
NFG
22
Next Financial Group
Texas
– +$69 +25 New
Wells Fargo
23
Wells Fargo
California
– +$517 +187 +1,336%

CELGZ Hedge Fund Activity: Q2 2014 in Review

24 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q2 2014, worth a combined $4.11M — down 18% from $5.03M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CELGZ positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Davenport & Co, adding an estimated $16.6K. The largest seller was FCG Advisors, cutting an estimated $453K.

  • 24 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q2 2014, up from 23 in Q1 2014.
  • Funds reported $4.11M of Celgene Corporation Contingent Value Rights stock for Q2 2014, down 18% quarter-over-quarter.
  • 2 funds opened new Celgene Corporation Contingent Value Rights positions in Q2 2014 and 1 closed out, a net change of +1 holder.
  • The largest Celgene Corporation Contingent Value Rights buyer in Q2 2014 was Davenport & Co, an estimated $16.6K added.
  • The largest Celgene Corporation Contingent Value Rights seller in Q2 2014 was FCG Advisors, an estimated $453K sold.

Based on aggregated 13F filings for Q2 2014.